BTRC and neoplasm: SMAD4 degradative defects in HPV-positive cell lines might be also explained by the fact that HPV downregulates βTRCP1 expression, leading to a lower expression of this ligase in HPV-positive HNC cell lines and tumours compared to HPV-negative.